In a plenary session at PAINWeek 2012, three mental health experts described innovative programs that have been developed to help improve care for patients with chronic pain and psychiatric comorbidities.
A combination of ibuprofen plus a high-dose H2-receptor antagonist such as famotidine may decrease ibuprofen-induced ulcer disease, according to a study presented at PAINWeek 2012.
LAS VEGAS, NV—A meta-analysis presented at PAINWeek 2012 of two OTC doses of ibuprofen showed that 400 mg provided significantly better overall pain relief compared with 200 mg over a 6-hour period.
Theramine, a prescription-only amino acid food product, may offer a safe alternative to traditional pharmaceutical products used to treat chronic back pain, according to a presentation at PAINWeek 2012.
Tapentadol extended-release tablets is efficacious in the management of moderate-to-severe chronic pain associated with diabetic peripheral neuropathy in adults, according study results presented at PAINWeek 2012.
When used in combination with pregabalin and gabapentin, lidocaine 5% patch is well tolerated and safe for postherpetic neuralgia (PHN), according to a presentation at PAINWeek 2012.
Nano-sized drug particle NSAIDs could be effective in the management of pain and warrant further evaluation, according a presentation at PAINWeek 2012.
Oral methylnaltrexone is generally safe and well tolerated in patients with chronic, non-cancer pain and opioid-induced constipation, according to results of a study presented at PAINWeek 2012.
Lidocaine patch 5% is effective and well-tolerated if applied to the face, trunk, or extremities, according to the results of a study in patients with postherpetic neuralgia reported during PAINWeek 2012.
Want to read more?
Please login or register first to view this content.